Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Aug-24 4:21 PM View:  | Eli Lilly & Co. (LLY) | 26-Aug-24 | Private Sale (Planned) | 750 | $950.00 | $712,500.00 | (8%) 8.84K to 8.09K | |
| 03-Jun-24 4:15 PM View: | Eli Lilly & Co. (LLY) | 03-Jun-24 | Private Sale (Planned) | 750 | $819.47 | $614,602.00 | (8%) 9.59K to 8.84K | |
| 11-Mar-24 4:27 PM View: | Eli Lilly & Co. (LLY) | 11-Mar-24 | Private Sale (Planned) | 750 | $753.60 | $565,200.00 | (7%) 10.34K to 9.59K | |
| 14-Feb-24 4:39 PM View: | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 1,254 | $737.26 | $924,524.00 | 14% 9.08K to 10.34K | |
| 04-Dec-23 4:17 PM View: | Eli Lilly & Co. (LLY) | 01-Dec-23 | Payment of Exercise | 2,142 | $591.04 | $1,266,010.00 | (19%) 11.23K to 9.09K | |
| 04-Dec-23 4:17 PM View: | Eli Lilly & Co. (LLY) | 01-Dec-23 | Option Exercise | 4,810 | -- | -- | 75% 6.42K to 11.23K | |
| 06-Nov-23 4:25 PM View: | Eli Lilly & Co. (LLY) | 06-Nov-23 | Private Sale (Planned) | 670 | $571.10 | $382,637.00 | (9%) 7.08K to 6.41K | |
| 22-Aug-23 4:34 PM View: | Eli Lilly & Co. (LLY) | 21-Aug-23 | Private Sale (Planned) | 600 | $546.51 | $327,906.00 | (8%) 7.68K to 7.08K | |
| 16-May-23 4:31 PM View: | Eli Lilly & Co. (LLY) | 15-May-23 | Private Sale (Planned) | 600 | $435.29 | $261,174.00 | (7%) 8.28K to 7.68K | |
| 01-Mar-23 4:31 PM View: | Eli Lilly & Co. (LLY) | 27-Feb-23 | Private Sale (Planned) | 600 | $322.47 | $193,482.00 | (7%) 8.88K to 8.28K | |
| 14-Feb-23 5:23 PM View: | Eli Lilly & Co. (LLY) | 10-Feb-23 | Grant | 1,904 | $345.12 | $657,108.00 | 27% 6.97K to 8.87K | |
| 06-Sep-22 4:22 PM View: | Eli Lilly & Co. (LLY) | 01-Sep-22 | Private Sale (Planned) | 1,000 | $301.00 | $301,000.00 | (13%) 7.97K to 6.97K | |
| 02-Jun-22 6:43 PM View: | Eli Lilly & Co. (LLY) | 01-Jun-22 | Private Sale (Planned) | 1,000 | $313.44 | $313,440.00 | (11%) 8.96K to 7.96K | |
| 28-Feb-22 4:38 PM View: | Eli Lilly & Co. (LLY) | 25-Feb-22 | Market Sale (Planned) | 1,660 | $243.84 | $404,774.00 | (16%) 10.62K to 8.96K | (7%) |
| 11-Feb-22 6:45 PM View: | Eli Lilly & Co. (LLY) | 09-Feb-22 | Grant | 2,947 | $243.27 | $716,917.00 | 38% 7.66K to 10.61K | 7% |
| 29-Apr-21 8:31 PM View: | Eli Lilly & Co. (LLY) | 28-Apr-21 | Market Sale | 3,000 | $181.38 | $544,140.00 | (28%) 10.65K to 7.65K | < 1% |
| 10-Feb-21 8:51 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 4,247 | $205.77 | $873,905.00 | 66% 6.39K to 10.64K | (2%) |
| 03-Mar-20 3:27 PM View: | Eli Lilly & Co. (LLY) | 02-Mar-20 | Market Sale (Planned) | 3,700 | $128.00 | $473,600.00 | (37%) 10.11K to 6.41K | (28%) |
| 13-Feb-20 6:23 PM View: | Eli Lilly & Co. (LLY) | 11-Feb-20 | Grant | 3,845 | $144.25 | $554,641.00 | 61% 6.29K to 10.13K | 13% |
| 22-Mar-19 3:16 PM View: | Eli Lilly & Co. (LLY) | 22-Mar-19 | Market Sale (Planned) | 1,000 | $128.50 | $128,500.00 | (14%) 7.26K to 6.26K | (26%) |
| 05-Mar-19 3:51 PM View: | Eli Lilly & Co. (LLY) | 01-Mar-19 | Market Sale (Planned) | 1,000 | $127.01 | $127,010.00 | (12%) 8.26K to 7.26K | (29%) |
| 06-Feb-19 8:29 PM View: | Eli Lilly & Co. (LLY) | 04-Feb-19 | Grant | 3,243 | $120.17 | $389,711.00 | 65% 5.01K to 8.25K | 36% |
| 01-Feb-19 10:00 PM View: | Eli Lilly & Co. (LLY) | 09-Nov-18 | Gift | 180 | -- | -- | (3%) 5.19K to 5.01K | |
| 04-Sep-18 4:50 PM View: | Eli Lilly & Co. (LLY) | 04-Sep-18 | Market Sale (Planned) | 600 | $105.57 | $63,342.00 | (15%) 4.13K to 3.53K | (54%) |
| 05-Mar-18 3:30 PM View: | Eli Lilly & Co. (LLY) | 01-Mar-18 | Market Sale | 860 | $76.50 | $65,790.00 | (13%) 6.63K to 5.77K | (110%) |
| 23-Feb-18 5:42 PM View: | Eli Lilly & Co. (LLY) | 21-Feb-18 | Market Sale | 876 | $77.55 | $67,933.80 | (12%) 7.48K to 6.6K | (107%) |
| 05-Feb-18 6:39 PM View: | Eli Lilly & Co. (LLY) | 05-Feb-18 | Market Sale | 900 | $81.09 | $72,981.00 | (11%) 8.38K to 7.48K | (97%) |
| 31-Jan-18 6:13 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-18 | Grant | 1,933 | $87.60 | $169,331.00 | 30% 6.44K to 8.38K | 82% |
| 05-Dec-17 5:48 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-17 | Payment of Exercise | 1,070 | $85.32 | $91,292.40 | (14%) 7.51K to 6.45K | (87%) |
| 05-Dec-17 5:48 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-17 | Option Exercise | 3,281 | -- | -- | 77% 4.23K to 7.51K | |
| 03-Feb-17 3:22 PM View: | Eli Lilly & Co. (LLY) | 02-Feb-17 | Market Sale | 2,000 | $77.52 | $155,040.00 | (33%) 6.13K to 4.13K | (106%) |
| 31-Jan-17 6:31 PM View: | Eli Lilly & Co. (LLY) | 27-Jan-17 | Grant | 2,586 | $75.38 | $194,933.00 | 73% 3.54K to 6.12K | 112% |
| 19-Dec-16 2:48 PM View: | Eli Lilly & Co. (LLY) | 16-Dec-16 | Market Sale | 1,000 | $72.13 | $72,130.00 | (22%) 4.53K to 3.53K | (121%) |
| 29-Jul-16 1:23 PM View: | Eli Lilly & Co. (LLY) | 28-Jul-16 | Market Sale | 1,213 | $83.16 | $100,873.00 | (20%) 6.0K to 4.79K | (94%) |
| 03-May-16 4:36 PM View: | Eli Lilly & Co. (LLY) | 02-May-16 | Market Sale | 600 | $76.53 | $45,918.00 | (9%) 6.57K to 5.96K | (112%) |
| 03-May-16 4:36 PM View: | Eli Lilly & Co. (LLY) | 29-Apr-16 | Market Sale | 1,000 | $75.45 | $75,450.00 | (13%) 7.57K to 6.57K | (115%) |
| 28-Jan-16 7:02 PM View: | Eli Lilly & Co. (LLY) | 26-Jan-16 | Grant | 2,003 | $81.96 | $164,166.00 | 28% 7.24K to 9.25K | 100% |
| 01-Jun-15 4:28 PM View: | Eli Lilly & Co. (LLY) | 29-May-15 | Market Sale | 200 | $78.33 | $15,666.00 | (3%) 7.33K to 7.13K | (112%) |
| 06-Feb-15 9:57 AM View: | Eli Lilly & Co. (LLY) | 05-Feb-15 | Market Sale | 374 | $71.03 | $26,565.20 | (5%) 7.66K to 7.29K | (137%) |
| 30-Jan-15 5:48 PM View: | Eli Lilly & Co. (LLY) | 28-Jan-15 | Grant | 1,373 | $70.97 | $97,441.80 | 22% 6.28K to 7.66K | 137% |
| 12-Nov-14 12:55 PM View: | Eli Lilly & Co. (LLY) | 11-Nov-14 | Market Sale | 750 | $68.49 | $51,367.50 | (11%) 7.0K to 6.25K | (147%) |
| 30-Jan-14 8:32 PM View: | Eli Lilly & Co. (LLY) | 28-Jan-14 | Grant | 1,373 | $54.23 | $74,457.80 | 25% 5.47K to 6.84K | 220% |
| 29-Jan-13 4:59 PM View: | Eli Lilly & Co. (LLY) | 25-Jan-13 | Grant | 1,300 | $53.21 | $69,173.00 | 33% 3.94K to 5.24K | 239% |
| 05-Dec-12 1:26 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-12 | Payment of Exercise | 517 | $49.04 | $25,353.70 | (12%) 4.45K to 3.93K | (267%) |
| 05-Dec-12 1:26 PM View: | Eli Lilly & Co. (LLY) | 03-Dec-12 | Option Exercise | 1,641 | -- | -- | 58% 2.81K to 4.45K |